• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 1.29% Nasdaq Down 3.25%

    Endocyte, Inc. (ECYT)

    -NasdaqGS
    3.02 Down 0.16(5.03%) Feb 5, 4:00PM EST
    Prev Close:3.18
    Open:3.18
    Bid:2.82 x 300
    Ask:3.27 x 600
    1y Target Est:10.00
    Beta:1.85999
    Earnings Date:Feb 29 - Mar 4 (Est.)
    Day's Range:3.01 - 3.18
    52wk Range:2.65 - 6.76
    Volume:164,242
    Avg Vol (3m):248,335
    Market Cap:126.77M
    P/E (ttm):N/A
    EPS (ttm):-0.95
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    ECYTDown 5.03%126.77M
    SNSSUp 3.28%67.88M
    NKTRUp 2.14%1.59B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):1,906.86
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-1.02
    Quarterly EPS Est (Dec-15) :-0.27
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Endocyte, Inc., a biopharmaceutical company, develops targeted therapies for the treatment of cancer and inflammatory diseases in the United States. The company uses its proprietary technology to create novel small molecule drug conjugates (SMDCs)... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback